Michael Borre

15.6k total citations
270 papers, 8.1k citations indexed

About

Michael Borre is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Michael Borre has authored 270 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Pulmonary and Respiratory Medicine, 76 papers in Molecular Biology and 72 papers in Cancer Research. Recurrent topics in Michael Borre's work include Prostate Cancer Treatment and Research (124 papers), Prostate Cancer Diagnosis and Treatment (82 papers) and Bladder and Urothelial Cancer Treatments (42 papers). Michael Borre is often cited by papers focused on Prostate Cancer Treatment and Research (124 papers), Prostate Cancer Diagnosis and Treatment (82 papers) and Bladder and Urothelial Cancer Treatments (42 papers). Michael Borre collaborates with scholars based in Denmark, United States and United Kingdom. Michael Borre's co-authors include Torben F. Ørntoft, Lars Dyrskjøt, Karina D. Sørensen, S. Høyer, Jens Overgaard, B Nerstrøm, Jørgen Bjerggaard Jensen, Mary Nguyen-Nielsen, Benedicte Parm Ulhøi and Mette Nørgaard and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Michael Borre

265 papers receiving 8.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Borre Denmark	48	3.6k	3.3k	2.9k	1.8k	1.7k	270	8.1k
David F. Jarrard United States	49	4.0k 1.1×	5.0k 1.5×	2.0k 0.7×	2.1k 1.2×	920 0.6×	207	10.0k
Anders Widmark Sweden	43	1.8k 0.5×	4.2k 1.3×	1.5k 0.5×	1.6k 0.9×	1.1k 0.6×	173	7.2k
Robert C. Flanigan United States	41	3.0k 0.8×	5.8k 1.7×	1.7k 0.6×	1.7k 1.0×	2.1k 1.3×	246	9.0k
Norio Nonomura Japan	49	4.6k 1.3×	3.6k 1.1×	1.8k 0.6×	2.4k 1.3×	2.3k 1.4×	598	11.4k
Masaru Murai Japan	44	2.4k 0.7×	2.7k 0.8×	1.3k 0.4×	1.3k 0.7×	1.3k 0.8×	234	6.5k
Armen Aprikian Canada	48	2.2k 0.6×	4.2k 1.3×	1.4k 0.5×	2.0k 1.1×	3.0k 1.8×	279	8.7k
Yoshiyuki Kakehi Japan	44	2.7k 0.7×	2.7k 0.8×	805 0.3×	1.6k 0.9×	1.9k 1.2×	262	7.0k
Chikara Οhyama Japan	43	3.5k 1.0×	2.6k 0.8×	803 0.3×	2.2k 1.2×	3.0k 1.8×	524	9.3k
David I. Quinn United States	59	4.0k 1.1×	4.8k 1.5×	2.3k 0.8×	5.8k 3.2×	4.5k 2.7×	420	14.1k
Louis Lacombe Canada	39	1.6k 0.5×	3.0k 0.9×	855 0.3×	3.4k 1.9×	2.7k 1.6×	179	7.2k

Countries citing papers authored by Michael Borre

Since Specialization

Citations

This map shows the geographic impact of Michael Borre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Borre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Borre more than expected).

Fields of papers citing papers by Michael Borre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Borre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Borre. The network helps show where Michael Borre may publish in the future.

Co-authorship network of co-authors of Michael Borre

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Borre. A scholar is included among the top collaborators of Michael Borre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Borre. Michael Borre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borre, Michael, Martin S. Bojer, Danae Morales Angeles, et al.. (2025). Temperature-dependent regulation of bacterial cell division hydrolases by the coordinated action of a regulatory RNA and the ClpXP protease. PubMed. 13. 100144–100144. 1 indexed citations

Dalton, Susanne Oksbjerg, Lau Caspar Thygesen, Erik Jakobsen, et al.. (2024). Cohort Profile: The Danish SEQUEL cohort. International Journal of Epidemiology. 53(1). 1 indexed citations

Salachan, Paul Vinu, Benedicte Parm Ulhøi, Michael Borre, & Karina D. Sørensen. (2023). Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters. Scientific Reports. 13(1). 2 indexed citations

Kjær, Trille Kristina, Lau Caspar Thygesen, Erik Jakobsen, et al.. (2023). Social inequality in cancer survivorship: Educational differences in health‐related quality of life among 27,857 cancer survivors in Denmark. Cancer Medicine. 12(19). 20150–20162. 12 indexed citations

Thomsen, Emil Aagaard, Johan Palmfeldt, Peter Bross, et al.. (2022). A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer. Oncogene. 41(37). 4271–4281. 26 indexed citations

Zhang, Yonghui, et al.. (2022). Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design. British Journal of Cancer. 127(12). 2186–2197. 6 indexed citations

Farkas, Dóra Körmendiné, et al.. (2021). Acute urinary retention and risk of cancer: population based Danish cohort study. BMJ. 375. n2305–n2305. 7 indexed citations

Bjerre, Marianne, Ole H. Larsen, Sarah Østrup Jensen, et al.. (2020). Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential. Cells. 9(6). 1362–1362. 27 indexed citations

Gulley, James L., Michael Borre, Nicholas J. Vogelzang, et al.. (2019). Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. 37(13). 1051–1061. 183 indexed citations

10.

Bjerre, Eik Dybboe, Christoffer Johansen, Peter Krustrup, et al.. (2019). Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial. PLoS Medicine. 16(10). e1002936–e1002936. 35 indexed citations

11.

Kirkegaard, Pia, Adrian Edwards, Torben F. Ørntoft, et al.. (2018). Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study. BMC Family Practice. 19(1). 32–32. 7 indexed citations

12.

Lamy, Philippe, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.. (2016). Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma. Cancer Research. 76(19). 5894–5906. 68 indexed citations

13.

Lajer, Henrik, Jens Hillingsø, S. Høyer, et al.. (2016). [The development of a generic guideline for multidisciplinary team conferences in Denmark].. PubMed. 178(39).

14.

Ording, Anne Gulbech, Erzsébet Horváth–Puhó, Timothy L. Lash, et al.. (2015). Does comorbidity interact with prostate cancer to increase mortality? A Danish cohort study of 45 326 prostate cancer patients diagnosed during 1995–2011. Acta Oncologica. 55(5). 611–618. 11 indexed citations

15.

Kayser, Lars, Michael Borre, Mette Borre, et al.. (2015). The Impact of Husbands’ Prostate Cancer Diagnosis and Participation in a Behavioral Lifestyle Intervention on Spouses’ Lives and Relationships With Their Partners. Cancer Nursing. 39(2). E1–E9. 13 indexed citations

16.

Kristensen, Helle, Christa Haldrup, Siri H. Strand, et al.. (2014). Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 20(8). 2169–2181. 73 indexed citations

17.

Reinert, Thomas, Charlotte Modin, Philippe Lamy, et al.. (2011). Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers. Clinical Cancer Research. 17(17). 5582–5592. 169 indexed citations

18.

Dyrskjøt, Lars, Marie S. Ostenfeld, Jesper B. Bramsen, et al.. (2009). Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro. Cancer Research. 69(11). 4851–4860. 315 indexed citations

19.

Sørensen, Karina D., Peter J. Wild, Ashkan Mortezavi, et al.. (2009). Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 15(4). 1400–1410. 25 indexed citations

20.

Vestergaard, Else Marie, Michael Borre, Steen Seier Poulsen, Ebba Nexø, & Niels Tørring. (2006). Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer. Clinical Cancer Research. 12(3). 807–812. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact